(Q53371446)

13 May 2018

title

Heparanase expression by Barrett's epithelium and during esophageal carcinoma progression. (English)

1 reference

13 May 2018

1 reference

Rita Brun

1

1 reference

13 May 2018

Inna Naroditsky

2

1 reference

13 May 2018

Matti Waterman

3

1 reference

13 May 2018

Ofer Ben-Izhak

4

1 reference

13 May 2018

Gabriel Groisman

5

1 reference

13 May 2018

Neta Ilan

6

1 reference

13 May 2018

Israel Vlodavsky

7

1 reference

13 May 2018

publication date

11 September 2009

1 reference

13 May 2018

published in

Modern Pathology

1 reference

13 May 2018

volume

22

1 reference

13 May 2018

page(s)

1548-1554

1 reference

13 May 2018

issue

12

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.115

exact match

0 references

cites work

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

Heparan sulphate proteoglycans fine-tune mammalian physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Basement membrane proteoglycans: from cellar to ceiling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Role of endothelial heparanase in delayed-type hypersensitivity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Mammalian heparanase: what is the message?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase: a target for drug discovery in cancer and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Development of heparanase inhibitors for anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase expression correlates with malignant potential in human colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Barrett's esophagus-emerging concepts and controversies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Diagnosis and grading of dysplasia in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase is overexpressed in lung cancer and correlates inversely with patient survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase upregulation by colonic epithelium in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Processing and activation of latent heparanase occurs in lysosomes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Non-anticoagulant heparins and inhibition of cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Clinical significance of urine heparanase in bladder cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

An ELISA method for the detection and quantification of human heparanase

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase induces Akt phosphorylation via a lipid raft receptor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase induces VEGF C and facilitates tumor lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Structure-function approach identifies a COOH-terminal domain that mediates heparanase signaling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase induces tissue factor expression in vascular endothelial and cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Human heparanase nuclear localization and enzymatic activity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase Expression Correlates with Invasion and Poor Prognosis in Gastric Cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

Heparanase regulates esophageal keratinocyte differentiation through nuclear translocation and heparan sulfate cleavage.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.115

7 January 2021

10.1038/MODPATHOL.2009.115

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

19749739

1 reference

13 May 2018